Literature DB >> 2985688

Ketanserin without effects on basal anterior pituitary hormone secretion in healthy subjects.

A Gordin, P Mustajoki, R Pelkonen.   

Abstract

The effect of ketanserin, a selective serotonin-2 (5-HT2) receptor blocking agent, on the secretion of anterior pituitary hormones was studied in 4 healthy volunteers. Ketanserin (10 mg) was administered as a slow iv injection and its effect was compared with that of saline. Ketanserin influenced neither the basal plasma levels of HGH, ACTH, TSH, LH or prolactin, nor the plasma levels of T4, T3, cortisol or glucose. Even if a single dose of ketanserin had no hormonal effects, this must also be studied after long term use.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985688     DOI: 10.1007/BF03350647

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

Review 1.  Regulatory peptides of the hypothalamus.

Authors:  W Vale; C Rivier; M Brown
Journal:  Annu Rev Physiol       Date:  1977       Impact factor: 19.318

Review 2.  Neuroendocrine consequences of chemical indolectomy.

Authors:  J H Jacoby; R F Thomas
Journal:  Ann N Y Acad Sci       Date:  1978-06-12       Impact factor: 5.691

3.  Neuropharmacological intervention on the pituitary-hypothalamic relationship.

Authors:  J Tuomisto
Journal:  Ann Clin Res       Date:  1978

Review 4.  Central neurotransmitters and the secretion of prolactin, GH, LH and TSH.

Authors:  L Krulich
Journal:  Annu Rev Physiol       Date:  1979       Impact factor: 19.318

5.  Acute blood-pressure-lowering effect of ketanserin.

Authors:  J De Cree; H Verhaegen; J Symoens
Journal:  Lancet       Date:  1981-05-23       Impact factor: 79.321

6.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

7.  Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

Authors:  G J Wenting; A J Man in 't Veld; A J Woittiez; F Boomsma; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

8.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

9.  In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.

Authors:  P M Laduron; P F Janssen; J E Leysen
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

10.  The antihypertensive effects of a pure and selective serotonin-receptor blocking agent (R 41 468) in elderly patients.

Authors:  J De Cree; J Leempoels; W De Cock; H Geukens; H Verhaegen
Journal:  Angiology       Date:  1981-02       Impact factor: 3.619

View more
  1 in total

1.  Effects of ritanserin, a novel serotonin-S2 receptor antagonist, on the secretion of pituitary hormones in normal humans.

Authors:  D Tepavcević; Z Giljević; M Korsić; S Halimi; E Suchanek; T Jelić; I Aganović; B Kozić; V Plavsić
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.